hydroxyurea has been researched along with digitoxose in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azad, N; Iyer, AK; Kaushik, V; Kulkarni, Y; O'Doherty, GA; Venkatadri, R; Wright, C; Yakisich, JS | 1 |
1 other study(ies) available for hydroxyurea and digitoxose
| Article | Year |
|---|---|
Digitoxin and its synthetic analog MonoD have potent antiproliferative effects on lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Digitoxin; Drug Synergism; Hexoses; Humans; Hydroxyurea; Inhibitory Concentration 50; Lung Neoplasms; Paclitaxel | 2016 |